期刊文献+

药物基因组学与临床个体化治疗

原文传递
导出
摘要 药物基因组学(pharmacogcnomics)是20世纪90年代末发展起来的基于功能基因组学(functional genomics)与分子药理学的一门科学.它从基因水平研究基因序列的多态性与药物效应多样性之间的关系,即研究基因本身及其突变体对不同个体药物作用效应差异的影响,以此为平台开发药物,指导合理用药,提高用药的安全性和有效性,避免不良反应,减少药物治疗的费用和风险[1].
作者 刘玉国
机构地区 [
出处 《中国临床实用医学》 2007年第4期-,共2页 China Clinical Practical Medicine
  • 相关文献

参考文献4

二级参考文献68

  • 1王军升,许振华,周宏灏.细胞色素P4503A4与药物氧化代谢[J].中国临床药理学杂志,1996,12(4):231-235. 被引量:13
  • 2Anderson JL,Carlquist JF,Home BD,et al. Cardiovascular pharmacogenomics:current status,future prospects[J]. J Cardiovasc Pharmacol Ther,2003,(1):1.
  • 3Evans WE,Relling MV. Pharmacogenomics:translating functional genomics into rational therapeutics[J]. Science,1999,86(5439) :87.
  • 4Eiselt R,Domanski TL,Zibat A,et al. Identification and functional characterization of eight CYP3A4 protein variants [J]. Pharmacogenetic,2001,1(5):47.
  • 5Sata F,Sapone A,Elizondo G,et al. CYP3A4 allelic variants with amino acid substitutions in axons 7 and 12:0 evidence for an allelic variant with altered catalytic activity[J]. Clin Pharmacol Ther ,000,67(1):8.
  • 6Felix CA,Walker AH,Lange BJ,et al. Association of CYP3A4 genotype with treatment related leukemia [J]. Proc Natl Acad Sci USA,1998,5:3176.
  • 7Harinder SM,Karen LG. Atorvastatin an updated review of its pharmacological properties and use in dyslipidaemia[J]. Drugs,2001,1(12):1835.
  • 8Gonzalez F,Skoda RC,Kimura S,et al. Characterization of the common genetic defect in humans in debrisoquine metabolism [J].Nature,1988,31:442.
  • 9Mulder AB,Van Lijf HJ,Bon MA,et al. Association of polymorphism in the cytochrome CYP2D6 and the efficacy and tolerability of simvastatin [J]. Clin Pharmacol Ther,2001,0(6):546.
  • 10Geisel J. The efficacy of simvastatin is not influenced by CYP2D6 polymorphism[J]. Clin Pharmacol Ther ,2002,0(11):95.

共引文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部